T 0517/14 (Ibandronate sodium, Form T/TEVA) of 19.06.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T051714.20150619
- Date of decision
- 19 June 2015
- Case number
- T 0517/14
- Petition for review of
- -
- Application number
- 08002626.3
- IPC class
- C07F 9/38A61P 19/10A61K 31/663
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Crystalline form of ibandronate sodium
- Applicant name
- Teva Pharmaceutical Industries Ltd
- Opponent name
- Hexal AG
Helm AG - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 56European Patent Convention Art 72European Patent Convention Art 72 1973
- Keywords
- Right of priority - assignment
Main request, allowable - Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is maintained unamended.